miR-375 maintains normal pancreatic α- and β-cell mass
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 ( miR-375 ), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 ( 375KO ) are hyperglycemic, exhibit increased total pancreatic α-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic β-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice ( ob / ob ), a model of increased β-cell mass, exhibit increased expression of miR-375 . Genetic deletion of miR-375 from these animals ( 375 / ob ) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, α- and β-cell turnover, and adaptive β-cell expansion in response to increasing insulin demand in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“knockout of miR-375 promotes progressive hyperglycemia in mouse models due to decreased insulin content and progressive loss of β-cell mass ( 32 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mir-375 is also involved in adaptive β-cell expansion in response to insulin resistance (518).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [518]
In the citing paper
“miR-375 also regulates many genes involved in cellular proliferation, which likely underlies its effect on the maintenance of beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
In the citing paper
“miR-375, an islet-specific microRNA that regulates both insulin secretion and beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · cited 1×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundMethodSelf-citationA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 6×
“Northern blotting, Western blotting, and luciferase assays were performed as previously described (13).”
BackgroundMethodResultInfluentialSelf-citationControl of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundThe Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundRegulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Bartel, D. P. (2018) · Cell · doi:10.1016/j.cell.2018.03.006 · Cited by 3,751
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
“The endocrine pancreas develops normally in miR-375 / mice yet these animals fail to appropriately expand pancreatic b cell mass in the setting of obesity-induced insulin resistance, resulting in severe diabetes (Poy et al., 2009).”
BackgroundHammond, S. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.001 · Cited by 1,284
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
“and for the maintenance of pancreatic α-cell and β-cell mass in mic”
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
D'Alessandra, Y., Devanna, P., Limana, F., Straino, S., Di Carlo, A., Brambilla, P. G., Rubino, M., Carena, M. C., Spazzafumo, L., De Simone, M., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq167 · Cited by 797
Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
Rorsman, P., & Ashcroft, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00008.2017 · Cited by 793
Self-citationTargeting noncoding RNAs in disease
Adams, B. D., Parsons, C., Walker, L., Zhang, W. C., & Slack, F. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci84424 · Cited by 673
Identification and consequences of miRNA–target interactions — beyond repression of gene expression
Hausser, J., & Zavolan, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3765 · Cited by 628
Self-citationCirculating miRNAs are correlated with tumor progression in prostate cancer
Brase, J. C., Johannes, M., Schlomm, T., Fälth, M., Haese, A., Steuber, T., Beissbarth, T., Kuner, R., & Sültmann, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.25376 · Cited by 587
Pirola, C. J., Fernández Gianotti, T., Castaño, G. O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Mirshahi, F., Sanyal, A. J., & Sookoian, S. (2015) · Gut · doi:10.1136/gutjnl-2014-306996 · Cited by 564
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
Kong, L., Zhu, J., Han, W., Jiang, X., Xu, M., Zhao, Y., Dong, Q., Pang, Z., Guan, Q., Gao, L., et al. (2011) · Acta Diabetologica · doi:10.1007/s00592-010-0226-0 · Cited by 529
Xu, H., Guo, S., Li, W., & Yu, P. (2015) · Scientific Reports · doi:10.1038/srep12453 · Cited by 534
The biological functions of miRNAs: lessons from in vivo studies
Vidigal, J. A., & Ventura, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.004 · Cited by 488
Noncoding RNAs, cytokines, and inflammation-related diseases
Marques-Rocha, J. L., Samblas, M., Milagro, F. I., Bressan, J., Martínez, J. A., & Marti, A. (2015) · The FASEB Journal · doi:10.1096/fj.14-260323 · Cited by 477
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Interplay between miRNAs and human diseases
Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., Singha, R. S., Malakar, A. K., & Chakraborty, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25854 · Cited by 420
Vienberg, S., Geiger, J., Madsen, S., & Dalgaard, L. T. (2017) · Acta Physiologica · doi:10.1111/apha.12681 · Cited by 373
“The phenotype of the global miR375 knockout (KO) (Poy et al. 2009) shows progressive hyperglycaemia with lower numbers of b-cells and impaired compensatory b-cell proliferation as well as effects on Na+ channel inactivation properties (Salunkhe et al. 2015a).”
BackgroundMathé, E. A., Nguyen, G. H., Bowman, E. D., Zhao, Y., Budhu, A., Schetter, A. J., Braun, R., Reimers, M., Kumamoto, K., Hughes, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1467 · Cited by 374
Deiuliis, J. A. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.170 · Cited by 349
MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems
Herranz, H., & Cohen, S. M. (2010) · Genes & Development · doi:10.1101/gad.1937010 · Cited by 364
“In vivo, mice mutant for miR-375 show reduced pancreatic b-cell mass and defects in energy homeostasis (Poy et al. 2009).”
BackgroundMiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2
Ding, L., Xu, Y., Zhang, W., Deng, Y., Si, M., Du, Y., Yao, H., Liu, X., Ke, Y., Si, J., et al. (2010) · Cell Research · doi:10.1038/cr.2010.79 · Cited by 341
The Cells of the Islets of Langerhans
Da Silva Xavier, G. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7030054 · Cited by 295
Adult-specific functions of animal microRNAs
Sun, K., & Lai, E. C. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3471 · Cited by 334
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 300
Diabetes mellitus, a microRNA-related disease?
Guay, C., Roggli, E., Nesca, V., Jacovetti, C., & Regazzi, R. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.009 · Cited by 300
Thioredoxin-interacting protein regulates insulin transcription through microRNA-204
Xu, G., Chen, J., Jing, G., & Shalev, A. (2013) · Nature Medicine · doi:10.1038/nm.3287 · Cited by 279
The emerging use of zebrafish to model metabolic disease
Seth, A., Stemple, D. L., & Barroso, I. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011346 · Cited by 270
“Subsequent studies showed that loss of miR-375 in mice leads to a reduction in β-cell number (Poy et al., 2009).”
BackgroundMicroRNA-7a regulates pancreatic β cell function
Latreille, M., Hausser, J., Stützer, I., Zhang, Q., Hastoy, B., Gargani, S., Kerr-Conte, J., Pattou, F., Zavolan, M., Esguerra, J. L. S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73066 · Cited by 281
“We previously reported that miR-375 is a critical regulator of β cell mass expansion in mice, as genetic deletion of Mir375 results in moderate hyperglycemia, partially phenocopying Rip-Cre dicer1 fl/fl knockout mice (15).”
Self-citationMelkman‐Zehavi, T., Oren, R., Kredo‐Russo, S., Shapira, T., Mandelbaum, A. D., Rivkin, N., Nir, T., Lennox, K. A., Behlke, M. A., Dor, Y., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.361 · Cited by 280
Zhu, H., & Leung, S. W. (2015) · Diabetologia · doi:10.1007/s00125-015-3510-2 · Cited by 271
de Souza Rocha Simonini, P., Breiling, A., Gupta, N., Malekpour, M., Youns, M., Omranipour, R., Malekpour, F., Volinia, S., Croce, C. M., Najmabadi, H., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1318 · Cited by 267
Role of microRNAs in diabetes and its cardiovascular complications
Shantikumar, S., Caporali, A., & Emanueli, C. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr300 · Cited by 263
“They also show increased numbers of a-cells and an elevated plasma glucagons.(20)”
BackgroundObesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
MicroRNA Exocytosis by Vesicle Fusion in Neuroendocrine Cells
Park, Y. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00355 · Cited by 261
“miR-375 is one of the first miRNAs that was identified in the pancreas; miR-375 regulates development of pancreatic islets (74) and normal pancreatic cell mass (71).”
BackgroundPullen, T. J., da Silva Xavier, G., Kelsey, G., & Rutter, G. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01433-10 · Cited by 258
MicroRNAs in Metabolic Disease
Fernández-Hernando, C., Ramírez, C. M., Goedeke, L., & Suárez, Y. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300144 · Cited by 257
Nguyen, H. C. N., Xie, W., Yang, M., Hsieh, C., Drouin, S., Lee, G. M., & Kantoff, P. W. (2013) · The Prostate · doi:10.1002/pros.22572 · Cited by 245
The emerging role of miR‐375 in cancer
Yan, J., Lin, J., & He, X. (2014) · International Journal of Cancer · doi:10.1002/ijc.28563 · Cited by 238
MicroRNAs in Vascular and Metabolic Disease
Zampetaki, A., & Mayr, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.247445 · Cited by 244
Chakraborty, C., Doss, C. G. P., Bandyopadhyay, S., & Agoramoorthy, G. (2014) · WIREs RNA · doi:10.1002/wrna.1240 · Cited by 238
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
Kong, K. L., Kwong, D. L. W., Chan, T. H.-M., Law, S. Y.-K., Chen, L., Li, Y., Qin, Y.-R., & Guan, X.-Y. (2012) · Gut · doi:10.1136/gutjnl-2011-300178 · Cited by 238
MicroRNAs in Obesity and Related Metabolic Disorders
Landrier, J.-F., Derghal, A., & Mounien, L. (2019) · Cells · doi:10.3390/cells8080859 · Cited by 223
Nesca, V., Guay, C., Jacovetti, C., Menoud, V., Peyot, M.-L., Laybutt, D. R., Prentki, M., & Regazzi, R. (2013) · Diabetologia · doi:10.1007/s00125-013-2993-y · Cited by 234
Changes in MicroRNA Expression Contribute to Pancreatic β-Cell Dysfunction in Prediabetic NOD Mice
Roggli, E., Gattesco, S., Caille, D., Briet, C., Boitard, C., Meda, P., & Regazzi, R. (2012) · Diabetes · doi:10.2337/db11-1086 · Cited by 227
MicroRNAs and Metabolism Crosstalk in Energy Homeostasis
Dumortier, O., Hinault, C., & Van Obberghen, E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.004 · Cited by 214
Analysis of microRNA knockouts in mice
Park, C. Y., Choi, Y. S., & McManus, M. T. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq367 · Cited by 208
MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its Complications
Fernandez-Valverde, S. L., Taft, R. J., & Mattick, J. S. (2011) · Diabetes · doi:10.2337/db11-0171 · Cited by 213
“Consistent with these studies, high levels of miR-375 are present in pancreatic islets of obese diabetic mouse models (ob/ob) (20) and T2D affected individuals (21).”
BackgroundResultRoles of microRNA on cancer cell metabolism
Chen, B., Li, H., Zeng, X., Yang, P., Liu, X., Zhao, X., & Liang, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-228 · Cited by 203
Wang, F., Li, Y., Zhou, J., Xu, J., Peng, C., Ye, F., Shen, Y., Lu, W., Wan, X., & Xie, X. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.07.037 · Cited by 205
van de Bunt, M., Gaulton, K. J., Parts, L., Moran, I., Johnson, P. R., Lindgren, C. M., Ferrer, J., Gloyn, A. L., & McCarthy, M. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055272 · Cited by 202
“Furthermore, knockdown of miR-375 in obese ob/ ob mice results in a more profound effect on glycaemia leading to a severe diabetic phenotype in these mice [40].”
BackgroundEpithelial microRNAs regulate gut mucosal immunity via epithelium–T cell crosstalk
Biton, M., Levin, A., Slyper, M., Alkalay, I., Horwitz, E., Mor, H., Kredo-Russo, S., Avnit-Sagi, T., Cojocaru, G., Zreik, F., et al. (2011) · Nature Immunology · doi:10.1038/ni.1994 · Cited by 201
Self-citationOxidative stress-mediated beta cell death and dysfunction as a target for diabetes management
Dinić, S., Arambašić Jovanović, J., Uskoković, A., Mihailović, M., Grdović, N., Tolić, A., Rajić, J., Đorđević, M., & Vidaković, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1006376 · Cited by 165
Jagadeeswaran, G., Zheng, Y., Sumathipala, N., Jiang, H., Arrese, E. L., Soulages, J. L., Zhang, W., & Sunkar, R. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-52 · Cited by 197
Meta-regulation: microRNA regulation of glucose and lipid metabolism
Lynn, F. C. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.05.007 · Cited by 187
Esguerra, J. L. S., Bolmeson, C., Cilio, C. M., & Eliasson, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018613 · Cited by 190
“. Recently it was shown that miR-375 knockout mice display elevated plasma glucose levels due to a small reduction in beta cell mass with a concomitant increase in the number of alpha cells per islet as well as increased circulating glucagon”
Wen, D., Peng, Y., Liu, D., Weizmann, Y., & Mahato, R. I. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.044 · Cited by 180
Circulating miR-375 as a Biomarker of β-Cell Death and Diabetes in Mice
Erener, S., Mojibian, M., Fox, J. K., Denroche, H. C., & Kieffer, T. J. (2013) · Endocrinology · doi:10.1210/en.2012-1744 · Cited by 182
Identification of Circulating miR-101, miR-375 and miR-802 as Biomarkers for Type 2 Diabetes
Higuchi, C., Nakatsuka, A., Eguchi, J., Teshigawara, S., Kanzaki, M., Katayama, A., Yamaguchi, S., Takahashi, N., Murakami, K., Ogawa, D., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2014.12.003 · Cited by 173
Seyhan, A. A., Nunez Lopez, Y. O., Xie, H., Yi, F., Mathews, C., Pasarica, M., & Pratley, R. E. (2016) · Scientific Reports · doi:10.1038/srep31479 · Cited by 174
Plasticity and Dedifferentiation within the Pancreas: Development, Homeostasis, and Disease
Puri, S., Folias, A. E., & Hebrok, M. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.001 · Cited by 162
“Pancreas organogenesis relies on microRNA production (Lynn et al., 2007), and several microRNAs, including miR-375, are implicated in b cell function and gene expression (Poy et al., 2004, 2009; Kaspi et al., 2014) as well as exocrine tissue homeostasis (Prevot et al., 2013).”
MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity
Jacovetti, C., Abderrahmani, A., Parnaud, G., Jonas, J.-C., Peyot, M.-L., Cornu, M., Laybutt, R., Meugnier, E., Rome, S., Thorens, B., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64151 · Cited by 171
Vallabhajosyula, P., Korutla, L., Habertheuer, A., Yu, M., Rostami, S., Yuan, C.-X., Reddy, S., Liu, C., Korutla, V., Koeberlein, B., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87993 · Cited by 165
You, L., Wang, N., Yin, D., Wang, L., Jin, F., Zhu, Y., Yuan, Q., & De, W. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25175 · Cited by 158
“Supernatants were collected at the indicated time and insulin concentrations were determined using radioimmunoassay (RIA) as previously described (Poy et al., 2009).”
BackgroundMethodMicroRNAs as stress regulators in pancreatic beta cells and diabetes
LaPierre, M. P., & Stoffel, M. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.020 · Cited by 158
“These animals exhibit a profoundly diminished proliferative capacity of the endocrine pancreas that results in a severely diabetic state and ultimately death [15].”
BackgroundInfluentialSelf-citationAssmann, T. S., Recamonde‐Mendoza, M., de Souza, B. M., & Crispim, D. (2017) · Endocrine Connections · doi:10.1530/ec-17-0248 · Cited by 171
Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes
Yang, Z., Chen, H., Si, H., Li, X., Ding, X., Sheng, Q., Chen, P., & Zhang, H. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0617-8 · Cited by 158
MicroRNAs in Insulin Resistance and Obesity
Williams, M. D., & Mitchell, G. M. (2012) · Experimental Diabetes Research · doi:10.1155/2012/484696 · Cited by 152
“This study also identified miR-375, an evolutionarily-conserved islet-specific miRNA, which has since become one of the best characterized isletspecific miRNAs implicated in both insulin secretion [8] and glucose homeostasis [19].”
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival
Avissar-Whiting, M., McClean, M. D., Kelsey, K. T., & Marsit, C. J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp277 · Cited by 162
Emerging role of microRNAs in liver diseases
Bala, S., Marcos, M., & Szabo, G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5633 · Cited by 155
Uptake and Function Studies of Maternal Milk-derived MicroRNAs
Title, A. C., Denzler, R., & Stoffel, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.676734 · Cited by 149
“Animals—375KO and 200cKO mice were generated as described previously on a C57BL/6N background (25, 29).”
BackgroundMethodSelf-citationArgonaute2 Mediates Compensatory Expansion of the Pancreatic β Cell
Tattikota, S. G., Rathjen, T., McAnulty, S. J., Wessels, H.-H., Akerman, I., van de Bunt, M., Hausser, J., Esguerra, J. L. S., Musahl, A., Pandey, A. K., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.015 · Cited by 152
“…also observed that expression 128 Cell Metabolism 19, 122–134, January 7, 2014 ª2014 Elsevier In of the growth suppressor Cadm1 was increased in islets of bAgo2KO mice, further indicating that the regulation of several targets of miR-375 was dependent on Ago2 (Figures 5A and 5B) (Poy et al., 2009).”
BackgroundMethodResultInfluentialSelf-citationmicroRNA in the development of diabetic complications
McClelland, A., & Kantharidis, P. (2013) · Clinical Science · doi:10.1042/cs20130079 · Cited by 159
Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice
Zhao, E., Keller, M. P., Rabaglia, M. E., Oler, A. T., Stapleton, D. S., Schueler, K. L., Neto, E. C., Moon, J. Y., Wang, P., Wang, I.-M., et al. (2009) · Mammalian Genome · doi:10.1007/s00335-009-9217-2 · Cited by 148
“Recent studies have shown that miR-375 plays a role in insulin expression (El Ouaamari et al. 2008), insulin secretion (Poy et al. 2004), and obesity-dependent b-cell proliferation (Poy et al. 2009).”
BackgroundResearch progress on Traditional Chinese Medicine syndromes of diabetes mellitus
Wang, J., Ma, Q., Li, Y., Li, P., Wang, M., Wang, T., Wang, C., Wang, T., & Zhao, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109565 · Cited by 156
Sebastiani, G., Pò, A., Miele, E., Ventriglia, G., Ceccarelli, E., Bugliani, M., Marselli, L., Marchetti, P., Gulino, A., Ferretti, E., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0675-y · Cited by 152
Regulatory Roles of MicroRNAs in Diabetes
Feng, J., Xing, W., & Xie, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101729 · Cited by 157
Beta-Cell Specific Deletion of Dicer1 Leads to Defective Insulin Secretion and Diabetes Mellitus
Kalis, M., Bolmeson, C., Esguerra, J. L. S., Gupta, S., Edlund, A., Tormo-Badia, N., Speidel, D., Holmberg, D., Mayans, S., Khoo, N. K. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029166 · Cited by 143
“. MiR-375 has also been implicated in β-cell expansion and proliferation”
BackgroundZhao, X., Mohan, R., Özcan, S., & Tang, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362632 · Cited by 132
“These regulatory functions are primarily maintained through miR-375-directed targeting of Myotrophin (MTPN), a protein that plays a key role in insulin secretion and exocytosis (14, 15).”
BackgroundLing, H., Wen, G., Feng, S., Tuo, Q., Ou, H., Yao, C. H., Zhu, B., Gao, Z., Zhang, L., & Liao, D. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05493.x · Cited by 148
“It also modulates b-cell functions by targeting PDK1 and maintains normal pancreatic a and b-cell mass.(24,29) MicroRNA-375 has also been reported to mediate neurite differentiation.”
BackgroundmiR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
Nishikawa, E., Osada, H., Okazaki, Y., Arima, C., Tomida, S., Tatematsu, Y., Taguchi, A., Shimada, Y., Yanagisawa, K., Yatabe, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1020 · Cited by 152
The Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137
Jiménez-Lucena, R., Camargo, A., Alcala-Diaz, J. F., Romero-Baldonado, C., Luque, R. M., van Ommen, B., Delgado‐Lista, J., Ordovás, J. M., Pérez‐Martínez, P., Rangel-Zúñiga, O. A., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0194-y · Cited by 146
Diabetes-induced male infertility: potential mechanisms and treatment options
Huang, R., Chen, J., Guo, B., Jiang, C., & Sun, W. (2024) · Molecular Medicine · doi:10.1186/s10020-023-00771-x · Cited by 155
“However, downregulation of miR-375 expression also results in a decrease in β cell mass (Poy et al. 2009).”
BackgroundmiR-375 Inhibits Differentiation of Neurites by Lowering HuD Levels
Abdelmohsen, K., Hutchison, E. R., Lee, E. K., Kuwano, Y., Kim, M. M., Masuda, K., Srikantan, S., Subaran, S. S., Marasa, B. S., Mattson, M. P., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00316-10 · Cited by 134
Peck, B. C. E., Mah, A. T., Pitman, W. A., Ding, S., Lund, P. K., & Sethupathy, P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.770099 · Cited by 133
Drosophila miR-14 regulates insulin production and metabolism through its target, sugarbabePreprint
Varghese, J., Lim, S. F., & Cohen, S. M. (2010) · Genes & Development · doi:10.1101/gad.1995910 · Cited by 137
Latreille, M., Herrmanns, K., Renwick, N., Tuschl, T., Malecki, M. T., McCarthy, M. I., Owen, K. R., Rülicke, T., & Stoffel, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1296-9 · Cited by 122
Self-citationThe Emerging Role of microRNAs and Nutrition in Modulating Health and Disease
Ross, S. A., & Davis, C. D. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105729 · Cited by 127
MiR-375, a microRNA related to diabetes.
Li, X.-L. (2014) · Gene · doi:10.1016/j.gene.2013.09.105 · Cited by 117
Application of microRNAs in diabetes mellitus
Chen, H., Lan, H.-Y., Roukos, D. H., & Cho, W. C. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0544 · Cited by 124
Gilbert, E. R., & Liu, D. (2012) · Epigenetics · doi:10.4161/epi.21238 · Cited by 119
Role of Caveolin-1 in Diabetes and Its Complications
Haddad, D., Madhoun, A. S. A., Nizam, R., & Al‐Mulla, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9761539 · Cited by 146
“It has been demonstrated that miR-124a activates CAV1 in podocytes, miR-375 downregulates CAV1 gene expression [74], and miR-204 can target CAV1 mRNA and decreases its expression in endothelial cells [75].”
BackgroundJiménez-Lucena, R., Rangel-Zúñiga, O. A., Alcala-Diaz, J. F., López-Moreno, J., Roncero‐Ramos, I., Molina‐Abril, H., Yubero‐Serrano, E. M., Caballero‐Villarraso, J., Delgado‐Lista, J., Castano, J. P., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.05.002 · Cited by 127
Baran-Gale, J., Kurtz, C. L., Erdos, M. R., Sison, C., Young, A., Fannin, E. E., Chines, P. S., & Sethupathy, P. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00352 · Cited by 120
“For example, miR-375-3p (another miRNA critical to beta cell function; Poy et al., 2004, 2009) is detected at levels∼6-fold lower by NEXTflex V2 than by TruSeq, although it is still identified as one of the most highly expressed miRNAs.”
BackgroundNovel functions for small RNA molecules.
Zhang, C. (2009) · PubMed · Cited by 143
Metadata
- Authors
- Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- Churchill Hospital (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-07
- Volume
- 106
- Issue
- 14
- Pages
- 5813-5818
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2656556
- OpenAlex
- W2073803015
- Cited by
- 740
- References
- 36
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 35 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 47 · 2017: 58 · 2016: 59 · 2015: 67 · 2014: 72 · 2013: 60 · 2012: 53
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114001, 3100A0)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- miR-375, microRNA, alpha cells, pancreatic beta cells, beta-cell mass, glucose homeostasis, hyperglycemia, glucagon, gluconeogenesis, hepatic glucose production, beta-cell proliferation, islet development, obesity, insulin resistance, diabetes mellitus, cell proliferation
- MeSH terms
- Animals, Blood Glucose, Homeostasis, Insulin, Islets of Langerhans, Mice, Obese, Mice, Knockout, MicroRNAs, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.